BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24762490)

  • 1. Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.
    Tarkan Y; Erkan A; Selcuk ES; Mehmet K; Tugba KF; Ozlem US; Suleyman A; Tulay A; Bilge A; Ramazan Y; Yusuf G; Mevlude I; Umut D; Ilhan O; Abdurrahman I; Alper S; Dogan U; Necati A; Berna O; Gok DA; Ugur Y; Mahmut G
    J Cancer Res Ther; 2014; 10(1):73-8. PubMed ID: 24762490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy.
    Guadagnolo BA; Zagars GK; Ballo MT; Patel SR; Lewis VO; Pisters PW; Benjamin RS; Pollock RE
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1173-80. PubMed ID: 17689031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.
    Wisanuyotin T; Radapat K; Sirichativapee W; Paholpak P; Kosuwon W; Sumnanoont C; Jeeravipoolvarn P
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):80-5. PubMed ID: 22898085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial sarcoma: the importance of size and location for survival.
    Deshmukh R; Mankin HJ; Singer S
    Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of prognostic factors for synovial sarcoma].
    Du ZY; Guo W; Yang RL; Yan TQ; Li DS
    Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):991-4. PubMed ID: 22333419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.
    Trassard M; Le Doussal V; Hacène K; Terrier P; Ranchère D; Guillou L; Fiche M; Collin F; Vilain MO; Bertrand G; Jacquemier J; Sastre-Garau X; Bui NB; Bonichon F; Coindre JM
    J Clin Oncol; 2001 Jan; 19(2):525-34. PubMed ID: 11208847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.
    Orbach D; Mc Dowell H; Rey A; Bouvet N; Kelsey A; Stevens MC
    Pediatr Blood Cancer; 2011 Dec; 57(7):1130-6. PubMed ID: 21495161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution.
    Palmerini E; Staals EL; Alberghini M; Zanella L; Ferrari C; Benassi MS; Picci P; Mercuri M; Bacci G; Ferrari S
    Cancer; 2009 Jul; 115(13):2988-98. PubMed ID: 19452538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.
    Sakabe T; Murata H; Konishi E; Takeshita H; Ueda H; Matsui T; Horie N; Yanagisawa A; Kubo T
    Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy.
    Okcu MF; Despa S; Choroszy M; Berrak SG; Cangir A; Jaffe N; Raney RB
    Med Pediatr Oncol; 2001 Aug; 37(2):90-6. PubMed ID: 11496345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
    Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
    Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.
    Spillane AJ; A'Hern R; Judson IR; Fisher C; Thomas JM
    J Clin Oncol; 2000 Nov; 18(22):3794-803. PubMed ID: 11078492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initially localized synovial sarcoma in adults: a retrospective single-center analysis of 26 patients registered at the Department of Oncology, University of Vienna between 2004 and 2013.
    Lamm W; Schur S; Köstler WJ; Amann G; Pokrajac B; Funovics P; Panotopoulos J; Brodowicz T
    Oncology; 2014; 87(1):48-57. PubMed ID: 24969357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival.
    Oda Y; Hashimoto H; Tsuneyoshi M; Takeshita S
    Am J Surg Pathol; 1993 Jan; 17(1):35-44. PubMed ID: 8383468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].
    Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.